ClearBridge Aggressive Growth FI (LMPFX)

181.94 +0.06  +0.03% Jan 17 USD
View Full Chart
Total Returns Chart

Key Stats

Net Asset Value 181.94
Turnover Ratio 2.00%
1 Year Fund Level Flows -2.436B

Performance & Returns

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 4.34% 5.96% 89
3M 13.31% 12.90% 45
6M 11.77% 11.43% 51
YTD 3.07% 4.59% 93
1Y 18.66% 29.96% 98
3Y 9.54% 18.81% 99
5Y 6.79% 13.59% 99
10Y 12.57% 13.77% 77
15Y 8.13% 9.82% --
20Y 6.41% 5.97% --
As of Jan. 17, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.12% 0.12% 0.00%
Stock 99.88% 99.88% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Dec. 31, 2019

Region Exposure

Americas 94.84%
North America 94.84%
Latin America 0.00%
Greater Europe 0.00%
United Kingdom 0.00%
Europe Developed 0.00%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 5.16%
Japan 0.00%
Australasia 0.00%
Asia Developed 5.16%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of Dec. 31, 2019. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 0.98%
Communication Services 31.01%
Consumer Cyclical 0.31%
Consumer Defensive 0.00%
Energy 1.59%
Financial Services 1.78%
Healthcare 30.96%
Industrials 4.55%
Real Estate 0.00%
Technology 28.83%
Utilities 0.00%
As of Dec. 31, 2019

Stock Market Capitalization

Giant 27.58%
Large 41.25%
Medium 25.18%
Small 5.86%
Micro 0.14%
As of Dec. 31, 2019

Stock Style Exposure

Large Cap Value 24.74%
Large Cap Blend 32.45%
Large Cap Growth 11.85%
Mid Cap Value 7.24%
Mid Cap Blend 10.80%
Mid Cap Growth 7.22%
Small Cap Value 3.07%
Small Cap Blend 1.04%
Small Cap Growth 1.60%
As of Dec. 31, 2019
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
CMCSA Comcast Corp Class A 9.10% 47.50 +1.34%
BIIB Biogen Inc 8.43% 285.50 -0.22%
UNH UnitedHealth Group Inc 7.20% 298.47 -0.75%
STX Seagate Technology PLC 5.15% 61.08 -0.73%
ADSK Autodesk Inc 4.72% 193.35 +0.44%
AVGO Broadcom Inc 4.50% 308.79 +0.57%
VRTX Vertex Pharmaceuticals Inc 4.39% 235.83 +0.14%
TEL TE Connectivity Ltd 3.90% 100.18 +0.68%
DISCA Discovery Inc Class A 3.20% 32.43 -1.04%
AMGN Amgen Inc 2.90% 241.49 +0.41%
As of Dec. 31, 2019
Advertisement

Basic Info

Investment Strategy
The investment seeks capital appreciation. The fund invests primarily in common stocks of companies the portfolio managers believe are experiencing, or will experience, growth in earnings exceeding the average rate of earnings growth of the companies which comprise the S&P 500 Index. It may invest in the securities of large, well-known companies offering prospects of long-term earnings growth. The fund may invest up to 25% of its net assets (at the time of investment) in foreign securities.
General
Security Type Mutual Fund
Oldest Share Symbol SHRAX
Equity Style Large Cap/Blend
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Large Growth
Prospectus Objective Aggressive Growth
Fund Owner Firm Name Legg Mason
Benchmark Index
Russell 3000 Growth TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Evan Bauman 10.69 yrs
Richard Freeman 36.21 yrs

Share Classes

Symbol Share Class
LMPRX Retirement
LSIFX Inst
SAGCX C
SAGYX Inst
SHRAX A

Net Fund Flows

1M -157.28M
3M -500.83M
6M -1.183B
YTD -2.436B
1Y -2.436B
3Y -6.379B
5Y -8.448B
10Y -5.907B
As of Dec. 31, 2019

Risk Info

Beta (5Y) 1.171
Historical Sharpe Ratio (10Y) 0.8761
Historical Sortino (All) 0.7689
Daily Value at Risk (VaR) 1% (All) 3.97%
Monthly Value at Risk (VaR) 1% (All) 16.76%

Fundamentals

Dividend Yield TTM (1-17-20) 0.38%
30-Day SEC Yield (12-16-11) 0.00%
7-Day SEC Yield (1-17-20) 0.00%
Weighted Average PE Ratio 17.22
Weighted Average Price to Sales Ratio 2.586
Weighted Average Price to Book Ratio 2.879
Weighted Median ROE 23.35%
Weighted Median ROA 8.14%
Forecasted Dividend Yield 1.36%
Forecasted PE Ratio 14.97
Forecasted Price to Sales Ratio 2.465
Forecasted Price to Book Ratio 2.766
Number of Holdings 58
As of Dec. 31, 2019

Growth Estimates

Forecasted 5 Yr Earnings Growth 9.63%
Forecasted Book Value Growth 7.15%
Forecasted Cash Flow Growth 18.37%
Forecasted Earnings Growth 12.42%
Forecasted Revenue Growth 6.97%
As of Dec. 31, 2019

Comparables

Edit

Attributes

Purchase Details
Open to New Investors Yes
Open to Existing Investors Yes
Minimum Initial Investment 0.00 USD
Minimum Subsequent Investment 0.00 USD
Fees
Actual 12B-1 Fee 0.25%
Actual Management Fee 0.70%
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
Key Dates
Inception Date 4/30/2007
Termination Date
Last Annual Report Date 8/31/2019
Last Prospectus Date 12/27/2019
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.